mesalamine and clobetasol

mesalamine has been researched along with clobetasol in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (66.67)18.2507
2000's1 (33.33)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL1
Fariña, MC; Grilli, R; Martín, L; Martínez, N; Requena, L; Soriano, ML1
Carrassi, A; Demarosi, F; Oltolina, A; Rimondini, L; Sardella, A1

Reviews

1 review(s) available for mesalamine and clobetasol

ArticleYear
Pyodermatitis-pyostomatitis vegetans: report of a case and review of the literature.
    Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics, 1999, Volume: 87, Issue:3

    Topics: Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Carboxymethylcellulose Sodium; Clobetasol; Colitis, Ulcerative; Diagnosis, Differential; Fluorescent Antibody Technique; Humans; Male; Mesalamine; Middle Aged; Mouth Mucosa; Pemphigus; Pyoderma; Stomatitis; Suppuration

1999

Trials

1 trial(s) available for mesalamine and clobetasol

ArticleYear
Efficacy of topical mesalazine compared with clobetasol propionate in treatment of symptomatic oral lichen planus.
    Oral diseases, 1998, Volume: 4, Issue:4

    Topics: Administration, Topical; Adult; Aged; Aged, 80 and over; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Clobetasol; Female; Glucocorticoids; Humans; Lichen Planus, Oral; Longitudinal Studies; Male; Mesalamine; Middle Aged; Pain Measurement; Statistics, Nonparametric; Treatment Outcome

1998

Other Studies

1 other study(ies) available for mesalamine and clobetasol

ArticleYear
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
    Current drug discovery technologies, 2004, Volume: 1, Issue:4

    Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration

2004